DrugPatentWatch Database Preview
Guerbet Company Profile
What is the competitive landscape for GUERBET, and what generic and branded alternatives to GUERBET drugs are available?
GUERBET has four approved drugs.
Summary for Guerbet
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 4 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | DISCN | No | No | See Pricing | See Pricing | |||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-001 | Mar 20, 2013 | RX | Yes | Yes | See Pricing | See Pricing | |||||
| Guerbet | LIPIODOL | ethiodized oil | OIL;INTRALYMPHATIC, INTRAUTERINE | 009190-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | See Pricing | See Pricing | |||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-003 | Mar 20, 2013 | RX | Yes | Yes | See Pricing | See Pricing | |||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-004 | Mar 20, 2013 | RX | Yes | Yes | See Pricing | See Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Guerbet | OXILAN-300 | ioxilan | INJECTABLE;INJECTION | 020316-001 | Dec 21, 1995 | 4,954,348 | See Pricing |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,014,986 | See Pricing |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,554 | See Pricing |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,094,966 | See Pricing |
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | 4,954,348 | See Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
